TL;DR
This study successfully isolated and characterized two distinct polysaccharides (LDP-A1 and LDP-B1) from the edible mushroom Lyophyllum decastes using ultrasound-assisted extraction. LDP-B1, with its unique triple-helix structure, demonstrated superior antioxidant, hypoglycemic, anti-inflammatory, and anti-tumor activities compared to LDP-A1, highlighting its potential for functional foods and pharmaceuticals.
What Problem Does This Paper Address?
Lyophyllum decastes, a rare edible mushroom, is recognized for its nutritional value and potential health benefits, largely attributed to its polysaccharides. However, research on extracting and characterizing these polysaccharides, particularly their structure-activity relationships, remains limited. Traditional hot water extraction methods can degrade sensitive components, potentially reducing bioactivity. This paper addresses the need for a more efficient extraction method (ultrasound-assisted extraction, UAE) and a comprehensive analysis of the resulting polysaccharides to understand their structural differences and their impact on various biological activities, paving the way for their application in functional foods and pharmaceuticals.
Methods
The study employed a multi-pronged approach:
- Ultrasound-Assisted Extraction (UAE): This technique was used for the initial extraction of crude polysaccharides, aiming for higher efficiency and reduced degradation compared to traditional methods.
- Chromatographic Separation: DEAE cellulose-52 ion-exchange chromatography and Sephacryl S-500 gel filtration chromatography were used to isolate and purify two distinct polysaccharide components, LDP-A1 and LDP-B1.
- Structural Analysis: A suite of analytical techniques was utilized:
- High-Performance Liquid Chromatography (HPLC): For determining monosaccharide composition and molecular weight.
- Fourier-Transform Infrared (FTIR) Spectroscopy: To identify functional groups and confirm the presence of β-glycosidic bonds.
- Scanning Electron Microscopy (SEM): To visualize the surface morphology and microstructures of the polysaccharides.
- X-Ray Diffraction (XRD): To assess the crystallinity and internal structure.
- Congo Red Staining: To investigate the presence of a triple-helix structure.
- Bioactivity Assays: In vitro assays were conducted to evaluate:
- Antioxidant Activity: ABTS and DPPH radical scavenging, and hydroxyl radical scavenging.
- Hypoglycemic Activity: Inhibition of α-amylase and α-glucosidase.
- Anti-inflammatory Activity: Effects on NO and cytokine (IL-6, TNF-α, IL-1β) secretion in LPS-stimulated RAW264.7 cells.
- Anti-tumor Activity: Inhibition of proliferation in various cancer cell lines (HT-29, HepG-2, MCF-7, A549).
Datasets
Not discussed in the paper.
Key Insights and Ideas
- UAE as an Effective Extraction Method: The study demonstrates the efficacy of UAE for extracting polysaccharides from L. decastes, yielding distinct fractions with varying properties.
- Structural Diversity Dictates Bioactivity: The most striking insight is the strong correlation between the structural characteristics of LDP-A1 and LDP-B1 and their biological activities. LDP-B1's unique triple-helix structure appears to be a key factor in its enhanced bioactivity.
- LDP-B1's Superior Performance: LDP-B1 consistently outperformed LDP-A1 across multiple bioactivity assays, suggesting it holds greater promise for therapeutic and functional applications.
- Triple-Helix Structure as a Bioactivity Driver: The presence of a triple-helix structure in LDP-B1, confirmed by Congo red staining, is highlighted as a significant factor contributing to its enhanced antioxidant and potentially other activities. This suggests that higher-order structural arrangements are crucial for polysaccharide function.
- Potential for Diabetes Management: The significant inhibitory effects of LDPs, particularly LDP-B1, on α-glucosidase and α-amylase suggest their potential as agents for managing postprandial blood glucose levels.
Key Results
- Two Distinct Polysaccharides: UAE and subsequent chromatography yielded two main polysaccharide components, LDP-A1 and LDP-B1, with significant differences in molecular weight (LDP-A1: 2.27 × 10⁶ Da; LDP-B1: 9.80 × 10⁵ Da) and monosaccharide composition.
- Structural Differences: LDP-A1 exhibited a rod-shaped morphology with a crystalline internal structure, while LDP-B1 displayed a sheet-like structure with an amorphous internal arrangement and a triple-helix configuration.
- Enhanced Bioactivity of LDP-B1:
- Antioxidant: LDP-B1 showed significantly stronger ABTS, DPPH, and hydroxyl radical scavenging abilities compared to LDP-A1.
- Hypoglycemic: LDP-B1 demonstrated more potent inhibition of α-glucosidase and α-amylase.
- Anti-inflammatory: LDP-B1 exhibited a more pronounced inhibitory effect on NO, IL-6, and TNF-α production.
- Anti-tumor: LDP-B1 showed better inhibition of HT-29 colon cancer cells.
- Safety Profile: Both LDP-A1 and LDP-B1 showed no significant cytotoxicity in the tested concentrations.
Limitations and Future Work
- In Vitro Focus: All bioactivity assessments were conducted in vitro. The authors acknowledge the need for in vivo studies to comprehensively evaluate the therapeutic potential and safety of LDPs.
- Mechanism Elucidation: While structural differences are linked to bioactivity, the precise molecular mechanisms underlying these effects require further exploration. The authors suggest further investigation into metabolic mechanisms and pharmacological evaluations.
- Structure-Activity Relationship Deep Dive: The study provides a foundation, but a more detailed understanding of how specific structural features (e.g., branching patterns, glycosidic bond configurations) precisely influence bioactivity is needed.
- Industrialization Potential: The authors express optimism about the potential for LDPs in functional foods and pharmaceuticals and aim to promote their further development and industrialization.
Summary updated